Avastin 25 mg/ml concentrate for solution for infusion, Erbitux 5 mg/mL solution for infusion clinical trials

SLURP; A phase 2 intervention study: Detection of early esophageal neoplastic lesions by quantified fluorescence molecular endoscopy using oral and topical administration of bevacizumab-800CW and cetuximab-800CW

This study is looking at a new way to find early changes in the food pipe, especially in people with a condition called Barrett's oesophagus. It uses special glowing liquids, given by mouth, to help doctors see these changes more clearly during a camera examination.